FHL transfer with fibrous Achilles tendon stump reinforcement has demonstrated excellent outcome. 6 Morbidity associated with FHL transfer is clinically insignificant, even for good push-off or balance in running sports. 7, 8 What led the authors to choose peroneus brevis as their first choice for augmentation? 5. Turco and Spinella modification 9 can be beneficial if a long distal stump is present. Did the authors use the same modification? During negotiation of peroneus brevis through a mid-coronal slit in the distal stump of the Achilles tendon, the stump might split. Did the authors experience this? What are the key factors to prevent this? 6. The authors evaluated patients at 3, 9, and 12 months using the Foot and Ankle Outcome Score (FAOS). At 3 and 9 months, the cohort was small. What were the causes for these dropouts? Were the patients lost to follow-up? 7. The small cohort prevents generalisation of the findings and leads to type-II errors. 10 We appreciate the authors' comment on this concern. 8. Were there any contraindications and/or limitations of peroneus brevis augmentation in terms of aetiology and/or critical size defect? We appreciate the authors' comments on this concern.
